VYNE Therapeutics is a company headquartered in the United States.
VYNE Therapeutics is a clinical-stage biopharmaceutical company focused on developing therapies that address difficult therapeutic challenges, primarily through its InhiBET™ BET inhibitor platform.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.